206 related articles for article (PubMed ID: 19891586)
1. The liver in 30-year-old individuals with alpha(1)-antitrypsin deficiency.
Bernspång E; Carlson J; Piitulainen E
Scand J Gastroenterol; 2009; 44(11):1349-55. PubMed ID: 19891586
[TBL] [Abstract][Full Text] [Related]
2. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
[TBL] [Abstract][Full Text] [Related]
3. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
Bernspång E; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2009 Jun; 103(6):861-5. PubMed ID: 19181511
[TBL] [Abstract][Full Text] [Related]
4. Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age.
Mostafavi B; Diaz S; Tanash HA; Piitulainen E
Medicine (Baltimore); 2017 Mar; 96(12):e6180. PubMed ID: 28328804
[TBL] [Abstract][Full Text] [Related]
5. Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency.
Bernspång E; Sveger T; Piitulainen E
Respir Med; 2007 Sep; 101(9):1971-6. PubMed ID: 17532199
[TBL] [Abstract][Full Text] [Related]
6. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
Piitulainen E; Mostafavi B; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
[TBL] [Abstract][Full Text] [Related]
7. Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ).
Tanash HA; Nilsson PM; Nilsson JA; Piitulainen E
Thorax; 2008 Dec; 63(12):1091-5. PubMed ID: 18682522
[TBL] [Abstract][Full Text] [Related]
8. Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children.
Lykavieris P; Ducot B; Lachaux A; Dabadie A; Broué P; Sarles J; Bernard O; Jacquemin E
J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):623-9. PubMed ID: 18955864
[TBL] [Abstract][Full Text] [Related]
9. Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.
Hsieh MH; Ho CK; Hou NJ; Hsieh MY; Lin WY; Yang JF; Chiu CC; Huang JF; Chang NC; Wang CL; Dai CY; Chuang WL; Yu ML
Int J Obes (Lond); 2009 Nov; 33(11):1309-17. PubMed ID: 19752878
[TBL] [Abstract][Full Text] [Related]
10. Variable degree of liver involvement in siblings with PiZZ alpha-1-antitrypsin deficiency-related liver disease.
Hinds R; Hadchouel A; Shanmugham NP; Al-Hussaini A; Chambers S; Cheeseman P; Mieli-Vergani G; Hadzić N
J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):136-8. PubMed ID: 16819392
[TBL] [Abstract][Full Text] [Related]
11. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
12. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
[TBL] [Abstract][Full Text] [Related]
13. CT lung densitometry in young adults with alpha-1-antitrypsin deficiency.
Bernspång E; Diaz S; Stoel B; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2011 Jan; 105(1):74-9. PubMed ID: 20674322
[TBL] [Abstract][Full Text] [Related]
14. Elevated liver enzymes in Turner syndrome during a 5-year follow-up study.
El-Mansoury M; Berntorp K; Bryman I; Hanson C; Innala E; Karlsson A; Landin-Wilhelmsen K
Clin Endocrinol (Oxf); 2008 Mar; 68(3):485-90. PubMed ID: 18167134
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
Papatheodoridis GV; Goulis J; Christodoulou D; Manolakopoulos S; Raptopoulou M; Andrioti E; Alexandropoulos N; Savvidou S; Papachristou A; Zervou E; Seferiadis K; Kousidou P; Vogiatzakis E; Tsianos E
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):281-7. PubMed ID: 17353691
[TBL] [Abstract][Full Text] [Related]
16. [Increased liver enzymes: what should be done?].
Renner EL; Dällenbach A
Ther Umsch; 1992 May; 49(5):281-6. PubMed ID: 1352416
[TBL] [Abstract][Full Text] [Related]
17. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study.
Monami M; Bardini G; Lamanna C; Pala L; Cresci B; Francesconi P; Buiatti E; Rotella CM; Mannucci E
Metabolism; 2008 Mar; 57(3):387-92. PubMed ID: 18249212
[TBL] [Abstract][Full Text] [Related]
18. Cardiac hepatopathy before and after heart transplantation.
Dichtl W; Vogel W; Dunst KM; Grander W; Alber HF; Frick M; Antretter H; Laufer G; Pachinger O; Pölzl G
Transpl Int; 2005 Jun; 18(6):697-702. PubMed ID: 15910296
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients.
Lobstein S; Kaiser T; Liebert U; Wojan M; Leichtle A; Mössner J; Wiegand J; Tillmann HL
Z Gastroenterol; 2008 May; 46(5):415-20. PubMed ID: 18461515
[TBL] [Abstract][Full Text] [Related]
20. Review of pyridoxal phosphate and the transaminases in liver disease.
Vanderlinde RE
Ann Clin Lab Sci; 1986; 16(2):79-93. PubMed ID: 3008634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
